Novavax continues to crumble - down another 14%.

Covid Vaccine stocks slipped another 0.7% on average. Fourteen stocks lost ground while 13 gained. 

Novavax took the biggest hit, falling 14%.  CureVac slipped 7% and Arcturus slipped another 6% after an unconvincing quarterly results conference call.

OncoSec, IMV, Dynavax and Immunity Bio all lost 5%. 

PDS Bio lead on the way up with a 7% gain, while Generex and Vaxart gained 5%.